Voyager Therapeutics Inc. (VYGR) Downgraded by Zacks Investment Research to Hold

Zacks Investment Research lowered shares of Voyager Therapeutics Inc ... s disease and preclinical programs comprise VY-SOD101 for a monogenic form of amyotrophic lateral sclerosis, VY-FXN01 for Friedreich ataxia and VY-HTT01 for Huntington’s disease ...